Operating Income (Loss) in USD of AXIM BIOTECHNOLOGIES, INC. from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Axim Biotechnologies, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2014 to Q2 2024.
  • Axim Biotechnologies, Inc. Operating Income (Loss) for the quarter ending 30 Jun 2024 was -$569K, a 18.4% increase year-over-year.
  • Axim Biotechnologies, Inc. Operating Income (Loss) for the twelve months ending 30 Jun 2024 was -$2.31M, a 40.2% increase year-over-year.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2023 was -$2.75M, a 40.9% increase from 2022.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2022 was -$4.65M, a 66.7% increase from 2021.
  • Axim Biotechnologies, Inc. annual Operating Income (Loss) for 2021 was -$14M, a 182% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.31M -$569K +$128K +18.4% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 -$2.44M -$402K +$309K +43.5% 01 Jan 2024 31 Mar 2024 10-Q/A 22 May 2024
Q4 2023 -$2.75M -$754K +$388K +34% 01 Oct 2023 31 Dec 2023 10-K 16 Apr 2024
Q3 2023 -$3.14M -$589K +$729K +55.3% 01 Jul 2023 30 Sep 2023 10-Q 20 Nov 2023
Q2 2023 -$3.87M -$698K +$362K +34.2% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 -$4.23M -$711K +$422K +37.3% 01 Jan 2023 31 Mar 2023 10-Q/A 22 May 2024
Q4 2022 -$4.65M -$1.14M +$6.51M +85.1% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 -$11.2M -$1.32M +$1.96M +59.8% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023
Q2 2022 -$13.1M -$1.06M +$1.12M +51.4% 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023
Q1 2022 -$14.2M -$1.13M -$265K -30.5% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023
Q4 2021 -$14M -$7.65M -$5.35M -233% 01 Oct 2021 31 Dec 2021 10-K 17 Apr 2023
Q3 2021 -$8.63M -$3.28M -$1.98M -152% 01 Jul 2021 30 Sep 2021 10-Q/A 15 Nov 2022
Q2 2021 -$6.65M -$2.18M -$1.52M -229% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2022
Q1 2021 -$5.13M -$868K -$179K -26% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q4 2020 -$4.95M -$2.3M -$2.55M -1012% 01 Oct 2020 31 Dec 2020 10-K/A 19 Apr 2022
Q3 2020 -$2.4M -$1.3M -$815K -169% 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021
Q2 2020 -$1.58M -$663K -$79.4K -13.6% 01 Apr 2020 30 Jun 2020 10-Q 23 Aug 2021
Q1 2020 -$1.5M -$689K +$1.6M +70% 01 Jan 2020 31 Mar 2020 10-Q/A 02 Jun 2021
Q4 2019 -$3.11M $252K +$975K 01 Oct 2019 31 Dec 2019 10-K/A 26 Apr 2021
Q3 2019 -$4.08M -$484K +$452K +48.3% 01 Jul 2019 30 Sep 2019 10-Q/A 27 Nov 2020
Q2 2019 -$4.54M -$583K +$758K +56.5% 01 Apr 2019 30 Jun 2019 10-Q/A 18 Aug 2020
Q1 2019 -$5.29M -$2.29M -$257K -12.6% 01 Jan 2019 31 Mar 2019 10-Q/A 02 Jul 2020
Q4 2018 -$5.04M -$723K +$327K +31.2% 01 Oct 2018 31 Dec 2018 10-K/A 20 May 2020
Q3 2018 -$5.36M -$936K +$249K +21% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$5.61M -$1.34M -$904K -207% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$4.71M -$2.04M -$1.56M -327% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 -$3.15M -$1.05M -$280K -36.4% 01 Oct 2017 31 Dec 2017 10-K 08 Apr 2019
Q3 2017 -$2.87M -$1.19M +$371K +23.8% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$3.24M -$437K +$54.2K +11% 01 Apr 2017 30 Jun 2017 10-Q/A 17 Aug 2018
Q1 2017 -$3.29M -$476K +$466K +49.4% 01 Jan 2017 31 Mar 2017 10-Q/A 18 May 2018
Q4 2016 -$3.76M -$770K +$5.54M +87.8% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018
Q3 2016 -$9.3M -$1.56M +$136K +8.02% 01 Jul 2016 30 Sep 2016 10-Q 20 Nov 2017
Q2 2016 -$9.43M -$491K +$1.07M +68.5% 01 Apr 2016 30 Jun 2016 10-Q/A 14 Sep 2017
Q1 2016 -$10.5M -$942K -$453K -92.7% 01 Jan 2016 31 Mar 2016 10-Q/A 14 Sep 2017
Q4 2015 -$10M -$6.31M 01 Oct 2015 31 Dec 2015 10-K/A 14 Sep 2017
Q3 2015 -$1.69M -$1.56M -1222% 01 Jul 2015 30 Sep 2015 10-Q/A 30 Nov 2016
Q2 2015 -$1.56M -$1.56M 01 Apr 2015 30 Jun 2015 10-Q/A 25 Aug 2016
Q1 2015 -$489K 01 Jan 2015 31 Mar 2015 10-Q/A 26 May 2016
Q3 2014 -$128K 01 Jul 2014 30 Sep 2014 10-Q 23 Nov 2015
Q2 2014 -$162* 01 Apr 2014 30 Jun 2014 10-Q/A 27 Aug 2015

AXIM BIOTECHNOLOGIES, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.75M +$1.9M +40.9% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 -$4.65M +$9.32M +66.7% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
2021 -$14M -$9.03M -182% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023
2020 -$4.95M -$1.84M -59.2% 01 Jan 2020 31 Dec 2020 10-K/A 19 Apr 2022
2019 -$3.11M +$1.93M +38.3% 01 Jan 2019 31 Dec 2019 10-K/A 26 Apr 2021
2018 -$5.04M -$1.89M -59.9% 01 Jan 2018 31 Dec 2018 10-K/A 20 May 2020
2017 -$3.15M +$610K +16.2% 01 Jan 2017 31 Dec 2017 10-K 08 Apr 2019
2016 -$3.76M +$6.29M +62.6% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018
2015 -$10M -$9.54M -1887% 01 Jan 2015 31 Dec 2015 10-K/A 14 Sep 2017
2014 -$506K 01 Jan 2014 31 Dec 2014 10-K/A 18 Apr 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.